Irinotecan and 5-fluorouracil in colorectal cancer: Time for a pause?

被引：5
|
作者：
Bulusu, VR [1 ]
机构：
[1] Addenbrookes Hosp, Ctr Oncol, Cambridge CB2 2QQ, England
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷 / 03期
关键词：
D O I：
10.1016/S0959-8049(97)10064-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：286 / 289
页数：4
相关论文
共 50 条
  • [1] Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer
    Fioravanti, Anna
    Canu, Bastianina
    Ali, Greta
    Orlandi, Paola
    Allegrini, Giacomo
    Di Desidero, Teresa
    Emrilenegger, Urban
    Fontanini, Gabriella
    Danesi, Romano
    Del Tacca, Mario
    Falcone, Alfredo
    Bocci, Guido
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 619 (1-3) : 8 - 14
  • [2] Beyond 5-fluorouracil monochemotherapy in colorectal cancer - It is time
    Satta, F
    Franchi, F
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 431 - 435
  • [3] Sirolimus,bevacizumab,5-Fluorouracil and irinotecan for advanced colorectal cancer:A pilot study
    Francois Ghiringhelli
    Boris Guiu
    Bruno Chauffert
    Sylvain Ladoire
    World Journal of Gastroenterology, 2009, 15 (34) : 4278 - 4283
  • [4] Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study
    Ghiringhelli, Francois
    Guiu, Boris
    Chauffert, Bruno
    Ladoire, Sylvain
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (34) : 4278 - 4283
  • [5] Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
    B Glimelius
    H Garmo
    Å Berglund
    L A Fredriksson
    M Berglund
    H Kohnke
    P Byström
    H Sørbye
    M Wadelius
    The Pharmacogenomics Journal, 2011, 11 : 61 - 71
  • [6] Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
    Glimelius, B.
    Garmo, H.
    Berglund, A.
    Fredriksson, L. A.
    Berglund, M.
    Kohnke, H.
    Bystrom, P.
    Sorbye, H.
    Wadelius, M.
    PHARMACOGENOMICS JOURNAL, 2011, 11 (01): : 61 - 71
  • [7] Identification of Predictive Markers of Response to 5-Fluorouracil and Irinotecan in Metastatic Colorectal Cancer
    Coyle, Vicky M.
    Allen, Wendy L.
    Boyer, John
    McLean, Estelle
    McCulla, Andrea
    Longley, Daniel B.
    Johnston, Patrick G.
    CANCER RESEARCH, 2006, 66 (08)
  • [8] Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil
    Hare, Jennifer I.
    Neijzen, Robert W.
    Anantha, Malathi
    Dos Santos, Nancy
    Harasym, Natashia
    Webb, Murray S.
    Allen, Theresa M.
    Bally, Marcel B.
    Waterhouse, Dawn N.
    PLOS ONE, 2013, 8 (04):
  • [9] A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
    M L Veronese
    W Sun
    B Giantonio
    J Berlin
    J Shults
    L Davis
    D G Haller
    P J O'Dwyer
    British Journal of Cancer, 2005, 92 : 1846 - 1849
  • [10] Colorectal cancer metastasis resectability after treatment with the the combination of 5-fluorouracil, oxaliplatin and irinotecan
    Manzano, Jose L.
    Yuste, Ana L.
    Alonso, Vicente
    Vega, Maria E.
    Marcuello, Eugenio
    Carrato, Alfredo
    Martinez-Villacampa, Mercedes
    Tabernero, Jose M.
    Sastre, Javier
    Abad, Albert
    ANNALS OF ONCOLOGY, 2006, 17 : 283 - 284
12345